Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tracing the stemness and malignant transition in a heritable colorectal cancer Lynch Syndrome by single-cell RNA-seq analysis. | Front Immunol | 2026 | 42266697 | PubTator, text mining | PubMed |
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet). | Front Immunol | 2026 | 42238576 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: molecular design, preclinical advances, and translational challenges. | Cancer Chemother Pharmacol | 2026 | 42207299 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions. | Biomolecules | 2026 | 42194027 | PubTator, text mining | PubMed |
| Dual-positive gastric cancer co-expressing AFP and CEA: an aggressive subtype defined by unique clinical and biological profiles. | Clin Exp Med | 2026 | 42154089 | PubTator, text mining | PubMed |
| Dissecting non-small cell lung cancer (NSCLC) with blood proteomics-from surgical to immunotherapeutic responses. | NPJ Precis Oncol | 2026 | 42120924 | PubTator, text mining | PubMed |
| A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort. | Lung Cancer | 2026 | 42068891 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Gastrointestinal Oncology: Clinical Efficacy and Inpatient Toxicity Management. | J Pers Med | 2026 | 42042562 | PubTator, text mining | PubMed |
| Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells. | Nature | 2026 | 42020746 | PubTator, text mining | PubMed |
| B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer. | Clin Cancer Res | 2026 | 42012455 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond. | J Thorac Oncol | 2026 | 41985715 | PubTator, text mining | PubMed |
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines. | Int J Mol Sci | 2026 | 41977278 | PubTator, text mining | PubMed |
| Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer. | Signal Transduct Target Ther | 2026 | 41956993 | PubTator, text mining | PubMed |
| Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen. | PET Clin | 2026 | 41951504 | PubTator, text mining | PubMed |
| Sarcomatoid carcinoma of the common bile duct: A case report and review of the literature. | Int Cancer Conf J | 2026 | 41929558 | PubTator, text mining | PubMed |
| Clinical application and optimization strategies for antibody-drug conjugates in solid tumors. | J Int Med Res | 2026 | 41904967 | PubTator, text mining | PubMed |
| Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder Cancer. | Biosensors (Basel) | 2026 | 41892063 | PubTator, text mining | PubMed |
| [Summary of second-line treatment of stage IV NSCLC without oncogenic addiction]. | Bull Cancer | 2026 | 41862326 | PubTator, text mining | PubMed |
| The roles and heterogeneity of CD8+ T cells in inflammatory bowel disease: A narrative review of insights from single‑cell transcriptomics (Review). | Int J Mol Med | 2026 | 41860039 | PubTator, text mining | PubMed |
| Integration of immunogenic cell death in the treatment landscape of non-small cell lung cancer: harnessing the power of the immune system. | Cell Death Discov | 2026 | 41851096 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=2